An Evaluation of The Relationship Between Falls, Osteoporosis And The Parkinson’s Disease Rating Scale In Patients With Parkinson’s Disease
- 28 June 2024
- journal article
- research article
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 14 (2) , 525-530
Abstract
Objective: The purpose of this study is to examine conditions such as balance disorder, risk of falling, fear of falling, vitamin D deficiency and osteoporosis in people with Parkinson's Disease (PD), and their association with the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) sub-components, which are used to follow-up these patients. Methods: The study comprised 38 patients who were followed up for idiopathic PD. All the patients’ demographic data, falls efficacy scale, number of falls within the last year, history of fractures, Berg Balance Scale, the MDS-UPDRS sub-components, vitamin D levels, and bone mineral densitometry values were recorded. Results: There was a positive correlation between the MDS-UPDRS Part I and the number of falls and the history of fractures, and a positive correlation with the Hoehn and Yahr scale, and the MDS-UPDRS Part II, III and total and the Berg Balance Scale, the Falls Efficacy Scale, and the number of falls. Our study found that the bone mineral densitometry values for the femoral neck were lower in women than in men, and there was a positive correlation between the bone mineral densitometry values for the femoral neck and the body mass index. A positive correlation was established between levodopa use and the falls efficacy scale. Conclusion: Falls, imbalance, osteoporosis are life-threatening conditions in patients with PD. This study established that the MDS-UPDRS, used to follow-up patients, was associated with these conditions. It is believed that this assessment method may also give an idea about these conditions in PD patients who are followed up using this scale.Keywords
This publication has 23 references indexed in Scilit:
- Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating ScaleMovement Disorders Clinical Practice, 2017
- Executive Summary of the 2013 International Society for Clinical Densitometry Position Development Conference on Body CompositionJournal of Clinical Densitometry, 2013
- Osteoporosis risk and bone mineral density levels in patients with Parkinson's disease: A meta-analysisBone, 2013
- Bone mineral density and vitamin D status in Parkinson’s disease patientsJournal of Neurology, 2012
- Reliability and validity of the Turkish version of the Falls Efficacy Scale International (FES-I) in community-dwelling older personsArchives of Gerontology and Geriatrics, 2012
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Prevalence and incidence of Parkinson's disease in EuropeEuropean Neuropsychopharmacology, 2005
- Body mass index as a predictor of fracture risk: A meta-analysisOsteoporosis International, 2005
- The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendationsMovement Disorders, 2003
- Prospective assessment of falls in Parkinson's diseaseJournal of Neurology, 2001